Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

DeltaNp63 antagonizes p53 to regulate mesoderm induction in Xenopus laevis.

Developmental biology | 2009

p63, a homolog of the tumor suppressor p53, is critical for the development and maintenance of complex epithelia. The developmentally regulated p63 isoform, DeltaNp63, can act as a transcriptional repressor, but the link between the transcriptional functions of p63 and its biological roles is unclear. Based on our initial finding that the mesoderm-inducing factor activin A is suppressed by DeltaNp63 in human keratinocytes, we investigated the role of DeltaNp63 in regulating mesoderm induction during early Xenopus laevis development. We find that down-regulation of DeltaNp63 by morpholino injection in the early Xenopus embryo potentiates mesoderm formation whereas ectopic expression of DeltaNp63 inhibits mesoderm formation. Furthermore, we show that mesodermal induction after down-regulation of DeltaNp63 is dependent on p53. We propose that a key function for p63 in defining a squamous epithelial phenotype is to actively suppress mesodermal cell fates during early development. Collectively, we show that there is a distinct requirement for different p53 family members during the development of both mesodermal and ectodermal tissues. These findings have implications for the role of p63 and p53 in both development and tumorigenesis of human epithelia.

Pubmed ID: 19272371 RIS Download

Research resources used in this publication

None found

Additional research tools detected in this publication

None found

Associated grants

  • Agency: NIEHS NIH HHS, United States
    Id: 5F30ES016504
  • Agency: NCI NIH HHS, United States
    Id: CA 20305301
  • Agency: NCI NIH HHS, United States
    Id: P50 CA095103
  • Agency: NCI NIH HHS, United States
    Id: T32 CA009385
  • Agency: NCI NIH HHS, United States
    Id: R01 CA105436
  • Agency: NCI NIH HHS, United States
    Id: P50 CA95103
  • Agency: NCI NIH HHS, United States
    Id: T32 CA078136
  • Agency: NIGMS NIH HHS, United States
    Id: R01 GM081635
  • Agency: NCI NIH HHS, United States
    Id: R01 CA070856
  • Agency: NCI NIH HHS, United States
    Id: T32CA078136-08
  • Agency: NIGMS NIH HHS, United States
    Id: 1 R01 GM081635-01
  • Agency: NIGMS NIH HHS, United States
    Id: R01 GM081635-02
  • Agency: NIEHS NIH HHS, United States
    Id: ES00267
  • Agency: NIEHS NIH HHS, United States
    Id: P30 ES000267
  • Agency: NCI NIH HHS, United States
    Id: CA105436
  • Agency: NIEHS NIH HHS, United States
    Id: F30 ES016504
  • Agency: NCI NIH HHS, United States
    Id: CA009385
  • Agency: NCI NIH HHS, United States
    Id: P30 CA068485
  • Agency: NIGMS NIH HHS, United States
    Id: R41 GM073407
  • Agency: NCI NIH HHS, United States
    Id: CA68485
  • Agency: NCI NIH HHS, United States
    Id: CA70856
  • Agency: NIGMS NIH HHS, United States
    Id: GM073407

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Mouse Anti-Newt skeletal muscle marker, 102 kDa Antibody, Unconjugated (antibody)

RRID:AB_531892

This unknown targets Mouse Newt skeletal muscle marker 102 kDa

View all literature mentions